Published online on August 22, 2003, 10.1073/pnas.1734137100
PNAS | September 2, 2003 | vol. 100 | no. 18 | 10429-10434
Previous Article |
Table of Contents
| Next Article
Medical Sciences
WNT7a induces E-cadherin in lung cancer cells
Tatsuo Ohira *,
Robert M. Gemmill *,
Kevin Ferguson *,
Sophie Kusy
,
Joëlle Roche
,
Elisabeth Brambilla
,
Chan Zeng
,
Anna Baron
,
Lynne Bemis *,
Paul Erickson *,
Elizabeth Wilder ¶,
Anil Rustgi ||,
Jan Kitajewski **,
Edward Gabrielson 
,
Roy Bremnes 
,
Wilbur Franklin 
, and
Harry A. Drabkin * 
*Division of Medical Oncology, Departments of
Biometrics/Preventive Medicine and

Pathology, University of Colorado
Health Sciences and Cancer Centers, 4200 East 9th Avenue, Denver, CO 80262;
Institut de Biologie Moléculaire et
d'Ingénierie Génétique, EA 2224, Université de
Poitiers, 40 Avenue du Recteur Pineau, 86022 Poitiers Cédex, France;
Laboratoire de Pathologie Cellulaire, Institut
National de la Santé et de la Recherche Médicale 9924, Centre
Hospitalo-Universitaire Albert Michallon, F-38043 Grenoble, France;
¶Department of Cell and Developmental Biology and
||Division of Gastroenterology, Department of
Genetics, and Abramson Cancer Center, University of Pennsylvania,
Philadelphia, PA 19104-6100; **Department of Pathology
and Center for Reproductive Sciences, Columbia University College of
Physicians and Surgeons, New York, NY 10032; and

Department of Pathology, Johns Hopkins
Medical Center, Baltimore, MD 21231
Communicated by David M. Prescott, University of Colorado, Boulder, CO,
July 3, 2003
(received for review April 9, 2003)
E-cadherin loss in cancer is associated with de-differentiation, invasion,
and metastasis. Drosophila DE-cadherin is regulated by
Wnt/
-catenin signaling, although this has not been demonstrated in
mammalian cells. We previously reported that expression of WNT7a, encoded on
3p25, was frequently downregulated in lung cancer, and that loss of E-cadherin
or
-catenin was a poor prognostic feature. Here we show that WNT7a both
activates E-cadherin expression via a
-catenin specific mechanism in
lung cancer cells and is involved in a positive feedback loop. Li+,
a GSK3
inhibitor, led to E-cadherin induction in an inositol-independent
manner. Similarly, exposure to mWNT7a specifically induced free
-catenin
and E-cadherin. Among known transcriptional suppressors of E-cadherin, ZEB1
was uniquely correlated with E-cadherin loss in lung cancer cell lines, and
its inhibition by RNA interference resulted in E-cadherin induction.
Pharmacologic reversal of E-cadherin and WNT7a losses was achieved with
Li+, histone deacetylase inhibition, or in some cases only with
combined inhibitors. Our findings provide support that E-cadherin induction by
WNT/
-catenin signaling is an evolutionarily conserved pathway operative
in lung cancer cells, and that loss of WNT7a expression may be important in
lung cancer development or progression by its effects on E-cadherin.
Abbreviations: NSCLC, non-small-cell lung cancer; TSA, trichostatin A; Ct
values, cycle threshold values; IMPase, inositol monophosphatase; HDAC,
histone deacetylase; siRNA, small interfering RNA.

To whom correspondence should be addressed. E-mail:
harry.drabkin{at}uchsc.edu.

CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:

|
 |

|
 |
 
T. R. Graham, H. E. Zhau, V. A. Odero-Marah, A. O. Osunkoya, K. S. Kimbro, M. Tighiouart, T. Liu, J. W. Simons, and R. M. O'Regan
Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Cancer Res.,
April 1, 2008;
68(7):
2479 - 2488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, J. M. Amann, T. Kikuchi, R. Porta, M. Guix, A. Gonzalez, K.-H. Park, D. Billheimer, C. L. Arteaga, H.-H. Tai, et al.
Inhibition of Epidermal Growth Factor Receptor Signaling Elevates 15-Hydroxyprostaglandin Dehydrogenase in Non-Small-Cell Lung Cancer
Cancer Res.,
June 15, 2007;
67(12):
5587 - 5593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Frederick, B. A. Helfrich, C. D. Coldren, D. Zheng, D. Chan, P. A. Bunn Jr., and D. Raben
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma
Mol. Cancer Ther.,
June 1, 2007;
6(6):
1683 - 1691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Fujii, L. You, Z. Xu, K. Uematsu, J. Shan, B. He, I. Mikami, L. R. Edmondson, G. Neale, J. Zheng, et al.
An Antagonist of Dishevelled Protein-Protein Interaction Suppresses {beta}-Catenin-Dependent Tumor Cell Growth
Cancer Res.,
January 15, 2007;
67(2):
573 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dohadwala, S.-C. Yang, J. Luo, S. Sharma, R. K. Batra, M. Huang, Y. Lin, L. Goodglick, K. Krysan, M. C. Fishbein, et al.
Cyclooxygenase-2-Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non-Small Cell Lung Cancer.
Cancer Res.,
May 15, 2006;
66(10):
5338 - 5345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Spoelstra, N. G. Manning, Y. Higashi, D. Darling, M. Singh, K. R. Shroyer, R. R. Broaddus, K. B. Horwitz, and J. K. Richer
The Transcription Factor ZEB1 Is Aberrantly Expressed in Aggressive Uterine Cancers.
Cancer Res.,
April 1, 2006;
66(7):
3893 - 3902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Witta, R. M. Gemmill, F. R. Hirsch, C. D. Coldren, K. Hedman, L. Ravdel, B. Helfrich, R. Dziadziuszko, D. C. Chan, M. Sugita, et al.
Restoring E-Cadherin Expression Increases Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cell Lines
Cancer Res.,
January 15, 2006;
66(2):
944 - 950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Yauch, T. Januario, D. A. Eberhard, G. Cavet, W. Zhu, L. Fu, T. Q. Pham, R. Soriano, J. Stinson, S. Seshagiri, et al.
Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients
Clin. Cancer Res.,
December 15, 2005;
11(24):
8686 - 8698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Thomson, E. Buck, F. Petti, G. Griffin, E. Brown, N. Ramnarine, K. K. Iwata, N. Gibson, and J. D. Haley
Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non-Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition
Cancer Res.,
October 15, 2005;
65(20):
9455 - 9462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, J. V. Zhang, Y.-J. Cao, J.-X. Zhou, W.-M. Liu, X.-J. Fan, and E.-K. Duan
Inhibition of the Beta-Catenin Signaling Pathway in Blastocyst and Uterus During the Window of Implantation in Mice
Biol Reprod,
March 1, 2005;
72(3):
700 - 706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Garnis, J. Campbell, J. J. Davies, C. MacAulay, S. Lam, and W. L. Lam
Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis
Hum. Mol. Genet.,
February 15, 2005;
14(4):
475 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|